A PD Solution to Protect Peritoneal Membranes

PD-protec® by Zytoprotec, which now has FDA orphan drug status, is in Phase III trials among 300 patients in the US and Europe. The product aims to reduce PD complications such as peritonitis and membrane failure.

Read the full article » | Posted 01-11-2018

Related Articles

• The Top 10 Catheter Innovations of 2020 Posted 01-12-2021
• Researchers Use Technology To Print Miniature Human Kidneys In Lab Posted 12-10-2020
• New Drug for Dialysis-related Itching Posted 11-12-2020
• Diality Raises $12.5M for its Portable Home HD System Posted 11-12-2020